[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353219-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353219-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ggt6-as-a-prognostic-biomarker-and-therapeutic-target-in-melanoma-using-an-information-theoretical-method","GGT6 as a Prognostic Biomarker and Therapeutic Target in Melanoma Using an Information-theoretical Method","","Melanoma is an aggressive malignancy with rising global incidence, and despite early surgical intervention, recurrence and treatment resistance continue to limit survival. Using the GSE126076 and melanoma datasets (Skin Cutaneous Melanoma, TCGA, PanCancer Atlas), information-theoretical analysis identified prognostic factors. Kaplan–Meier survival analysis with log-rank testing showed that high GGT6 expression correlated with shorter disease-specific survival in all stages. In vitro, DON reduced melanoma cell proliferation and decreased intracellular GSH levels, supporting GGT inhibition as a potential therapeutic strategy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ggt6-as-a-prognostic-biomarker-and-therapeutic-target-in-melanoma-using-an-information-theoretical-method/353219/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ggt6-as-a-prognostic-biomarker-and-therapeutic-target-in-melanoma-using-an-information-theoretical-method/353219.png","ImageObject",300,407,{"name":42,"@type":43},"Bulrr","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in melanoma care?","Question",{"text":63,"@type":64},"Melanoma has increasing incidence, and even with early surgical treatment, recurrence and treatment resistance remain major challenges. The study targets the need for prognostic biomarkers and therapeutic targets.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was GGT6 identified as related to prognosis?",{"text":68,"@type":64},"The study analyzed melanoma datasets using an information-theoretical method, then performed Kaplan–Meier survival analysis with log-rank tests. High GGT6 expression was significantly associated with shorter disease-specific survival across stages.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the in vitro experiments show about inhibiting GGT?",{"text":72,"@type":64},"Melanoma cells treated with the GGT inhibitor DON showed reduced cell proliferation in A375 and A2058 cells. Treatment also lowered intracellular GSH levels compared with controls, supporting a role for GGT in melanoma cell viability.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353219,1790363527,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","doi: 10.21873/cgp.20603  \nGGT6 as a Prognostic Biomarker and Therapeutic Target in Melanoma Using an Information-theoretical Method  \nYI-FEI YANG1, YUN GENG1, HUI XU1, KAZUNORI AKIMOTO2,3, YUN-WEN ZHENG1,2,4,5,6, YUYUN XIONG1 andYU-MEI LI1  \n1 Institute of Regenerative Medicine, and Department of Dermatology, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, P. R. China;  \n2 Department of Medical and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan;  \n3 Research Division of Medical Data Science, Research Institute for Science and Technology, Tokyo University of Science, Chiba, Japan;  \n4Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine and South China Institute of Large Animal Models for Biomedicine, Wuyi University, Jiangmen, P. R. China;  \n5School of Pharmacy and Food Engineering, Wuyi University, Jiangmen, P. R. China;  \n6Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan  \nAbstract  \nBackground/Aim: Melanoma is an aggressive malignancy with rising global incidence. While early surgical intervention improves survival in localized cases, treatment resistance and recurrence remain a challenge. This underscores the critical need to identify prognostic biomarkers for early diagnosis, personalized treatment, and novel therapeutic development. Materials and Methods: The GSE126076 and melanoma dataset (Skin Cutaneous Melanoma, TCGA, PanCancer Atlas) were analyzed using an information-theoretical method to identify prognostic factors. Survival analysis was performed via Kaplan-Meier curves and log-rank tests to compare high-and low-mRNA expression groups. In vitro, A375 cells and A2058 cells were treated with the GGT inhibitor 6-diazo-5-oxo-L-norleucin (DON) . Cell viability was assessed using the CCK-8 assay and intracellular GSH levels were measured following treatment.  \nResults: Through information-theoretic analysis and survival analysis, we identified GGT6 asa prognostic gene in melanoma. Survival analysis revealed that high GGT6 expression was significantly associated with shorter disease-specific survival across all disease stages. In vitro, 10 µMDON for 72 hreduced A375 cell proliferation by 90.72% versus control (p\u003C0.0001), with an IC₅₀ of 5.14 µM; and reduced A2058 cell proliferation by 60.93%(p\u003C0.0001), with an IC₅₀ of 7.93 µM. Measurement continued  \nIJiante ogfsu URegenniveerartsitivye,ZhenMedicjiianne,ga,Jniangsd Depua,rPt.Rm.eChinnt ofaD. Teerl: +mat8o6lo1g3y,914Affi5li6a48te3d0H,oes-mpiataill:oxfiJongyuyuiangsu Unn@uivejrssedty,uJi. cannagndsuYUuni-MveerisiLity,,  \nYu-Yun Xiong, Institute of Regenerative Medicine, and Department of Dermatology, Affiliated Hospital of Jiangsu University,  \nZhenjiang, Jiangsu, P.R. China. Tel: +86 13914569541, e-mail: [l.yumei@aliyun.com](l.yumei@aliyun.com)  \n[Received April 15](Received April 15), 2026 | Revised May 30, 2026 | Accepted June 2, 2026  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©2026 The Author(s) . Published by the International Institute of Anticancer Research.  \nof GSH levels ofA375 andA2058 cells revealed that melanoma cells treated with 10 µM DON exhibited lower GSH levels compared with the respective control groups (p\u003C0.0001 and p=0.0042, respectively).  \nConclusion: Our study is the first to demonstrate the association between GGT6 expression levels and melanoma prognosis, and reveals that GGT inhibition suppresses melanoma cell viability. These findings provide new insights into the mechanisms of melanoma development and progression, and suggest GGT as a potential therapeutic target for clinical treatment.  \nKeywords: Gamma-glutamyltransferase, melanoma, information-theoretical method, tumor prognosis, tumor treatment.  \nIntroduction  \nMe","cbCaiiRo7ILBTqj2","https://ap.wps.com/l/cbCaiiRo7ILBTqj2","pdf",5139330,17,"English","# Abstract\n## Background/Aim\n## Materials and Methods\n## Results\n## Conclusion\n# Introduction\n## Melanoma incidence and clinical challenges\n## Information-theoretical analysis in life sciences\n# Keywords","[{\"question\":\"What problem does the study address in melanoma care?\",\"answer\":\"Melanoma has increasing incidence, and even with early surgical treatment, recurrence and treatment resistance remain major challenges. The study targets the need for prognostic biomarkers and therapeutic targets.\"},{\"question\":\"How was GGT6 identified as related to prognosis?\",\"answer\":\"The study analyzed melanoma datasets using an information-theoretical method, then performed Kaplan–Meier survival analysis with log-rank tests. High GGT6 expression was significantly associated with shorter disease-specific survival across stages.\"},{\"question\":\"What did the in vitro experiments show about inhibiting GGT?\",\"answer\":\"Melanoma cells treated with the GGT inhibitor DON showed reduced cell proliferation in A375 and A2058 cells. Treatment also lowered intracellular GSH levels compared with controls, supporting a role for GGT in melanoma cell viability.\"}]","GGT6 as a Prognostic Biomarker and Therapeutic Target in Melanoma Using an Information-theoretical Method | PDF",1790103623,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9e3ece1a82a1e99be2707867417a0c4.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3df3d32c597f048cbd50ccbce397570.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8f239a9e2e306b22e4d9d769427051b.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36114b44b268e17bbaa662009d549093.webp",980,1306]